SE0403160D0 - New compounds - Google Patents
New compoundsInfo
- Publication number
- SE0403160D0 SE0403160D0 SE0403160A SE0403160A SE0403160D0 SE 0403160 D0 SE0403160 D0 SE 0403160D0 SE 0403160 A SE0403160 A SE 0403160A SE 0403160 A SE0403160 A SE 0403160A SE 0403160 D0 SE0403160 D0 SE 0403160D0
- Authority
- SE
- Sweden
- Prior art keywords
- compounds
- disorders
- related disorders
- orexin
- sup
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
- C07D491/02—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
- C07D491/10—Spiro-condensed systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D493/00—Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system
- C07D493/02—Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system in which the condensed system contains two hetero rings
- C07D493/10—Spiro-condensed systems
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
Priority Applications (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
SE0403160A SE0403160D0 (sv) | 2004-12-23 | 2004-12-23 | New compounds |
US11/318,126 US20060217375A1 (en) | 2004-12-23 | 2005-12-22 | New compounds |
PCT/EP2005/057132 WO2006067224A2 (en) | 2004-12-23 | 2005-12-22 | Spiro-benzodioxole and spiro-benzodioxane compounds as orexin receptor antagonists |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
SE0403160A SE0403160D0 (sv) | 2004-12-23 | 2004-12-23 | New compounds |
Publications (1)
Publication Number | Publication Date |
---|---|
SE0403160D0 true SE0403160D0 (sv) | 2004-12-23 |
Family
ID=34102109
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
SE0403160A SE0403160D0 (sv) | 2004-12-23 | 2004-12-23 | New compounds |
Country Status (2)
Country | Link |
---|---|
US (1) | US20060217375A1 (sv) |
SE (1) | SE0403160D0 (sv) |
Families Citing this family (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP5524083B2 (ja) | 2008-01-30 | 2014-06-18 | セファロン、インク. | ヒスタミン−3(h3)受容体リガンドとしての置換スピロ環状ピペリジン誘導体 |
MX2010008382A (es) * | 2008-01-30 | 2010-11-25 | Cephalon Inc | Derivados de piperidina espirociclicos substituidos, como ligandos de receptores de histamina-3 (h3). |
DE102008025893B4 (de) * | 2008-05-26 | 2014-09-18 | Technische Universität Dresden | Verfahren zur Herstellung von Fettsäureamiden mit gesättigten, ungesättigten oder Hydroxy-Fettsäuren |
WO2010044441A1 (ja) | 2008-10-17 | 2010-04-22 | 塩野義製薬株式会社 | 血管内皮リパーゼ阻害活性を有する酢酸アミド誘導体 |
-
2004
- 2004-12-23 SE SE0403160A patent/SE0403160D0/sv unknown
-
2005
- 2005-12-22 US US11/318,126 patent/US20060217375A1/en not_active Abandoned
Also Published As
Publication number | Publication date |
---|---|
US20060217375A1 (en) | 2006-09-28 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
WO2006067224A3 (en) | Spiro-benzodioxole and spiro-benzodioxane compounds as orexin receptor antagonists | |
JP6233454B2 (ja) | Trk阻害化合物 | |
NO20084318L (no) | Inhibitorer av II-beta-hydroksystereoid dehydrogenase I | |
PH12016502294A1 (en) | Novel fatty acids and their use in conjugation to biomolecules | |
CY1112398T1 (el) | Πυρρολιδινονες υποκατασταθεισες απο κυκλοεξυλιο ως αναστολεις της 11-β-υδροξυστεροειδικης αφυδρογονασης 1 | |
CY1109842T1 (el) | Αναστολεις της αφυδρογονασης 11-β-υδροξυστεροειδων i | |
DE602006009095D1 (en) | Diacylglycerol-acyltransferase-hemmer | |
EA200870475A1 (ru) | Ингибиторы 11-бета-гидроксистероид-дегидрогеназы типа 1 | |
WO2010036613A8 (en) | Novel cyclic benzimidazole derivatives useful anti-diabetic agents | |
MY160256A (en) | Novel indole compounds | |
DE602005013822D1 (de) | Cycloalkylaminderivate | |
RU2010120808A (ru) | Производное амина, обладающее активностью антагониста npy y5 рецептора, и его применение | |
EA200970088A1 (ru) | Модуляторы метаболизма и лечение связанных с ним нарушений | |
CL2007002347A1 (es) | Compuestos derivados de fenilo, piridina y quinolina; procedimiento de preparacion; composicion farmaceutica; y uso del compuesto en el tratamiento de diabetes mellitus, trastornos en la tolerancia de la glucosa, obesidad, enfermedad de crohn, enferm | |
PE20120620A1 (es) | Dihidropirazolonas sustituidas como inhibidores de hif-propil-4-hidroxilasas | |
JP2009514837A5 (sv) | ||
UY28774A1 (es) | Derivados de heteroarilaminopirazol utiles para el tratamiento de la diabetes. | |
NO20062509L (no) | Tetrazolderivater og fremgangsmater for behandling av stoffskifterelaterte forstyrrelser derav | |
JO2937B1 (en) | Tight muscles of the peptide vascular tensioner receptor | |
GB0524814D0 (en) | Compounds | |
DE602007013040D1 (de) | 4-Ä(3-FLUORPHENOXY)PHENYLMETHYLÜPIPERIDINMETHANiSULFONAT: VERWENDUNGEN, SYNTHESEVERFAHREN UND PHARMAZEUTISCHE ZUSAMMENSETZUNGEN | |
EA201000926A1 (ru) | Пиперазины в качестве агентов против ожирения | |
WO2007144768A3 (en) | Use of peptidic vasopressin receptor agonists | |
SE0403160D0 (sv) | New compounds | |
CL2007002366A1 (es) | Sales maleato, tosilato, fumarato y oxalato de 5-(1(s)-amino-2-hidroxietil)-n-[(2,4-difluorofenil)-metil]-2-[8-metoxi-2-(trifluorometil)-5-quinolin]-4-oxazolcarboxamida; proceso de preparacion de dichas sales, utiles para el tratamiento de afecciones |